Department of Epidemiology and Biostatistics, College for Public Health and Social Justice, Saint Louis University, Saint Louis, MO, USA.
Department of Clinical Analytics, SSM Health, 10101 Woodfield Lane, Saint Louis, MO, USA.
Sci Rep. 2021 May 11;11(1):10022. doi: 10.1038/s41598-021-89554-0.
Patients with locally advanced colon cancer have worse outcomes. Guidelines of various organizations are conflicting about the use of laparoscopic colectomy (LC) in locally advanced colon cancer. We determined whether patient outcomes of LC and open colectomy (OC) for locally advanced (T4) colon cancer are comparable in all colon cancer patients, T4a versus T4b patients, obese versus non-obese patients, and tumors located in the ascending, descending, and transverse colon. We used data from the 2013-2015 American College of Surgeons' National Surgical Quality Improvement Program. Patients were diagnosed with nonmetastatic pT4 colon cancer, with or without obstruction, and underwent LC (n = 563) or OC (n = 807). We used a composite outcome score (mortality, readmission, re-operation, wound infection, bleeding transfusion, and prolonged postoperative ileus); length of stay; and length of operation. Patients undergoing LC exhibited a composite outcome score that was 9.5% lower (95% CI - 15.4; - 3.5) versus those undergoing OC. LC patients experienced a 11.3% reduction in postoperative ileus (95% CI - 16.0; - 6.5) and an average of 2 days shorter length of stay (95% CI - 2.9; - 1.0). Patients undergoing LC were in the operating room an average of 13.5 min longer (95% CI 1.5; 25.6). We found no evidence for treatment heterogeneity across subgroups (p > 0.05). Patients with locally advanced colon cancer who receive LC had better overall outcomes and shorter lengths of stay compared with OC patients. LC was equally effective in obese/nonobese patients, in T4a/T4b patients, and regardless of the location of the tumor.
局部晚期结肠癌患者的预后较差。各种组织的指南对于局部晚期结肠癌患者中腹腔镜结肠切除术(LC)的应用存在争议。我们旨在确定 LC 和开腹结肠切除术(OC)治疗局部晚期(T4)结肠癌的患者结局是否在所有结肠癌患者、T4a 与 T4b 患者、肥胖与非肥胖患者以及升结肠、降结肠和横结肠癌患者中具有可比性。我们使用了来自 2013-2015 年美国外科医师学会国家手术质量改进计划的数据。患者被诊断为非转移性 pT4 结肠癌,伴有或不伴有梗阻,并接受了 LC(n = 563)或 OC(n = 807)。我们使用了复合结局评分(死亡率、再入院、再次手术、伤口感染、出血输血和术后肠麻痹延长)、住院时间和手术时间。与接受 OC 的患者相比,接受 LC 的患者复合结局评分低 9.5%(95%CI-15.4;-3.5)。LC 患者术后肠麻痹减少 11.3%(95%CI-16.0;-6.5),住院时间平均缩短 2 天(95%CI-2.9;-1.0)。LC 患者在手术室的时间平均延长 13.5 分钟(95%CI 1.5;25.6)。我们没有发现治疗异质性的证据(p > 0.05)。与 OC 患者相比,接受 LC 的局部晚期结肠癌患者总体结局更好,住院时间更短。LC 在肥胖/非肥胖患者、T4a/T4b 患者以及肿瘤位置方面同样有效。